BRIEF-Incyte initiates clinical trial of Ruxolitinib for treatment of essential thrombocythemia
November 15, 2017 at 07:37 AM EST
* Incyte announces initiation of pivotal clinical trial of Ruxolitinib (Jakafi®) for the treatment of essential thrombocythemia